GSDMD and cirrhosis of liver: Immunohistochemical assays showed that NLRP3, GSDMD, caspase-1 and CK19 were more highly expressed in the liver cirrhosis group than in the other groups, and the levels in the medium and high dose Exo-rBMMSC groups were dramatically decreased (Figure 5C–F).